E50 (Etoposide 50 mg)
Pill imprint E50 has been identified as Etoposide 50 mg.
Etoposide is used in the treatment of small cell lung cancer; ovarian cancer; hodgkin's lymphoma; testicular cancer; cancer and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- E50
- Strength:
- 50 mg
- Color:
- Pink
- Size:
- 23.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Mitotic inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3266
- Inactive Ingredients:
- citric acid anhydrous
gelatin
glycerin
hypromellose
ferric oxide red
polyethylene glycol
propylene glycol
water
ferrosoferric oxide
titanium dioxide
More about etoposide
Consumer resources
- Etoposide
- Etoposide capsules
- Etoposide injection
- Etoposide phosphate
- Etoposide (Advanced Reading)
- Etoposide Oral, Intravenous (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
